SCHEMBL5745867

SCHEMBL5745867

c1ccc2c(c1)-c1ccccc1C2OCCCN1CCCC1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
HTT P42858 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
KDM4E B2RXH2 5/20 0.49
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
PKM P14618 1/20 0.49
HRH3 Q9Y5N1 11/20 0.48
KCNH2 Q12809 3/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
HRH1 P35367 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5749058 0.98 ALDH1A1 (0.51) ALDH1A1HTTL3MBTL1KDM4EKMT2A
SCHEMBL5747294 0.97 ALDH1A1 (0.47) ALDH1A1HTTL3MBTL1KDM4EKMT2A
SCHEMBL5745895 0.90 HRH3 (0.52) ALDH1A1HTTL3MBTL1KDM4EHRH3
SCHEMBL5746120 0.89 HRH3 (0.54) ALDH1A1KDM4EKMT2AMEN1PKM
SCHEMBL5748202 0.73 HTR2A (0.45) HRH3HRH1TP53
SCHEMBL11231045 0.71 LTA4H (0.44) ALDH1A1L3MBTL1KMT2AMEN1HRH3
SCHEMBL11669781 0.71 ALDH1A1 (0.45) ALDH1A1HTTL3MBTL1KDM4EKMT2A
SCHEMBL5746264 0.70 ALDH1A1 (0.54) ALDH1A1HTTL3MBTL1KDM4EKMT2A
SCHEMBL492205 0.69 HRH3 (0.84) ALDH1A1KDM4EHRH3KCNH2HRH1
SCHEMBL5747939 0.69 HTR1B (0.49) L3MBTL1KDM4EKMT2AMEN1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1711463-A2 AMINO-SUBSTITUTED TRICYCLIC DERIVATIVES AND METHODS OF USE ABBOTT LABORATORIES (US) 2006-10-18 EP disclosed
WO-2005077899-A2 AMINO-SUBSTITUTED TRICYCLIC DERIVATIVES AND METHODS OF USE ABBOTT LABORATORIES (US) 2005-08-25 WO disclosed